help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanamoto, H.
Right arrow Articles by Yoshie, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanamoto, H.
Right arrow Articles by Yoshie, O.
(American Journal of Pathology. 2004;164:997-1006.)
© 2004 American Society for Investigative Pathology

Expression of CCL28 by Reed-Sternberg Cells Defines a Major Subtype of Classical Hodgkin’s Disease with Frequent Infiltration of Eosinophils and/or Plasma Cells

Hitoshi Hanamoto*, Takashi Nakayama{dagger}, Hajime Miyazato*, Sumio Takegawa{dagger}, Kunio Hieshima{dagger}, Yoichi Tatsumi*, Akihisa Kanamaru* and Osamu Yoshie{dagger}

From the Department of Hematology, Nephrology, and Rheumatology,* and the Department of Microbiology,{dagger} Kinki University School of Medicine, Osaka, Japan

Classical Hodgkin’s disease (HD) is characterized by rare neoplastic Hodgkin and Reed-Sternberg (H-RS) cells within abundant reactive cellular backgrounds. In most cases, H-RS cells originate from the B-cell lineage, but their immunophenotypes are unusual. Here we newly found frequent expression of chemokine receptors CXCR6 and CCR10 and their respective ligands CXCL16 and CCL28 in HD-derived cell lines. CCR10 is known to be selectively expressed by plasma cells, whereas CCL28 attracts eosinophils via CCR3 and plasma cells via CCR10 and CCR3. Therefore, we examined their expression in HD tissues by immunohistochemistry. We found that H-RS cells in 15 of 19 cases were positive for CCL28. Among them, seven cases were also positive for CCR10, suggesting a potential autocrine effect. In situ hybridization confirmed the expression of CCL28 mRNA in H-RS cells. The CCL28 positivity in H-RS cells did not significantly correlate with that of LMP-1, CCL17, CCL22, or CCL11. However, it significantly correlated with the background accumulation of eosinophils, plasma cells, and CCR10+ cells. Thus, the production of CCL28 by H-RS cells may play a major role in tissue accumulation of eosinophils and/or plasma cells in classical HD. The frequent expression of CCR10 in H-RS cells themselves also supports their close relationship to plasma cells.





This article has been cited by other articles:


Home page
BloodHome page
A. Navarro, T. Diaz, A. Martinez, A. Gaya, A. Pons, B. Gel, C. Codony, G. Ferrer, C. Martinez, E. Montserrat, et al.
Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma
Blood, October 1, 2009; 114(14): 2945 - 2951.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Wang, Y. Lu, J. Wang, A. E. Koch, J. Zhang, and R. S. Taichman
CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway
Cancer Res., December 15, 2008; 68(24): 10367 - 10377.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Morteau, C. Gerard, B. Lu, S. Ghiran, M. Rits, Y. Fujiwara, Y. Law, K. Distelhorst, E. M. Nielsen, E. D. Hill, et al.
An Indispensable Role for the Chemokine Receptor CCR10 in IgA Antibody-Secreting Cell Accumulation
J. Immunol., November 1, 2008; 181(9): 6309 - 6315.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
Y. Lu, J. Wang, Y. Xu, A. E. Koch, Z. Cai, X. Chen, D. L. Galson, R. S. Taichman, and J. Zhang
CXCL16 Functions as a Novel Chemotactic Factor for Prostate Cancer Cells In vitro
Mol. Cancer Res., April 1, 2008; 6(4): 546 - 554.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. Re, R. Kuppers, and V. Diehl
Molecular Pathogenesis of Hodgkin's Lymphoma
J. Clin. Oncol., September 10, 2005; 23(26): 6379 - 6386.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.